Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, …
Over the last 12 months, insiders at Embecta Corp. have bought $32,500 and sold $0 worth of Embecta Corp. stock.
On average, over the past 5 years, insiders at Embecta Corp. have bought $271,966 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Melcher David F (director) — $65,000.
The last purchase of 2,000 shares for transaction amount of $32,500 was made by Melcher David F (director) on 2024‑02‑12.
2024-02-12 | director | 2,000 0.0027% | $16.25 | $32,500 | -5.42% | |||
2023-09-08 | director | 6,233 0.0082% | $15.77 | $98,271 | -6.83% | |||
2023-08-10 | President and CEO | 5,000 0.0091% | $21.81 | $109,050 | -27.30% | |||
2023-08-10 | SVP and CFO | 4,625 0.0083% | $21.66 | $100,195 | -27.30% | |||
2023-08-10 | SVP, GC, Head Corp. Dev., Secy | 4,700 0.0085% | $21.67 | $101,849 | -27.30% | |||
2023-02-15 | director | 3,100 0.0085% | $32.92 | $102,068 | -40.16% |
Melcher David F | director | 45080 0.0776% | $20.28 | 3 | 0 | <0.0001% |
Kurdikar Devdatt | President and CEO | 244791 0.4211% | $20.28 | 1 | 0 | <0.0001% |
Elguicze Jacob | SVP and CFO | 66027 0.1136% | $20.28 | 1 | 0 | <0.0001% |
Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | 55333 0.0952% | $20.28 | 1 | 0 | <0.0001% |